Related Experiment Video

Updated: Oct 8, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

[Pathophysiology and current therapy of congestive heart failure due to idiopathic cardiomyopathy]

M Kambayashi1, T Kumada

  • 1Department of Internal Medicine, Faculty of Medicine, Kyoto University.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|May 1, 1993
PubMed

Insights

Congestive heart failure (CHF) management differs for dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM). ACE inhibitors and beta-blockade are key for DCM, while verapamil and beta-blockade aid HCM patients.

Area of Science:

  • Cardiology
  • Internal Medicine

Context:

  • Idiopathic cardiomyopathies are a significant cause of congestive heart failure (CHF).
  • Dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM) present distinct pathophysiological mechanisms leading to CHF.

Purpose:

  • To review the current understanding and management strategies for congestive heart failure (CHF) arising from idiopathic cardiomyopathies, specifically DCM and HCM.
  • To highlight the pharmacological approaches and their efficacy in improving patient outcomes.

Summary:

  • Congestive heart failure in DCM is primarily due to myocardial systolic dysfunction. First-line treatments include diuretics, angiotensin-converting enzyme (ACE) inhibitors, and digitalis, with ACE inhibitors proven to prolong life and enhance quality of life. Long-term beta-blockade therapy has also demonstrated significant benefits.
  • In contrast, CHF in HCM results from decreased myocardial compliance. Verapamil improves relaxation and diastolic filling, and alleviates myocardial ischemia. Beta-blockade is beneficial by reducing the pressure gradient and myocardial oxygen consumption.
  • Idiopathic restrictive cardiomyopathy, though rare, also causes CHF due to decreased myocardial compliance.

Impact:

  • This review provides a concise overview of therapeutic options for managing CHF in different idiopathic cardiomyopathy subtypes.
  • Understanding these distinctions is crucial for optimizing treatment strategies and improving prognosis for patients with these complex cardiac conditions.

More Related Videos

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...